Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trolamine Retention Enema for Preventing Radiation-induced Rectal Injury
NCT06325982Recruiting
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of trolamine in radiation-induced rectal injury, sponsored by Fujian Medical University Cancer Hospital. Primary endpoints: Occurrence time of acute and chronic radiation rectal injury at 4 months and Evaluation of acute and chronic radiation rectal injury at 4 months. Started Jun 2024; status: recruiting.
02
Drugs
trolamine
03
Conditions
radiation-induced rectal injury
Beyond the preview
Go deeper on NCT06325982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06325982.